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Abstract
Multimodal classification methods using different modalities of imaging and non-imaging data 
have recently shown great advantages over traditional single-modality-based ones for diagnosis 
and prognosis of Alzheimer’s disease (AD), as well as its prodromal stage, i.e., mild cognitive 
impairment (MCI). However, to the best of our knowledge, most existing methods focus on 
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mining the relationship across multiple modalities of the same subjects, while ignoring the 
potentially useful relationship across different subjects. Accordingly, in this paper, we propose a 
novel learning method for multimodal classification of AD/MCI, by fully exploring the 
relationships across both modalities and subjects. Specifically, our proposed method includes two 
subsequent components, i.e., label-aligned multi-task feature selection and multimodal 
classification. In the first step, the feature selection learning from multiple modalities are treated as 
different learning tasks and a group sparsity regularizer is imposed to jointly select a subset of 
relevant features. Furthermore, to utilize the discriminative information among labeled subjects, a 
new label-aligned regularization term is added into the objective function of standard multi-task 
feature selection, where label-alignment means that all multi-modality subjects with the same class 
labels should be closer in the new feature-reduced space. In the second step, a multi-kernel support 
vector machine (SVM) is adopted to fuse the selected features from multi-modality data for final 
classification. To validate our method, we perform experiments on the Alzheimer’s Disease 
Neuroimaging Initiative (ADNI) database using baseline MRI and FDG-PET imaging data. The 
experimental results demonstrate that our proposed method achieves better classification 
performance compared with several state-of-the-art methods for multimodal classification of AD/
MCI.
Keywords
Alzheimer’s disease; mild cognitive impairment; label alignment; multi-task learning; feature 
selection; multimodal classification
I. Introduction
Alzheimer’s disease (AD) is a physical disease that affects the brain and is the most 
common cause of dementia. There were more than 26.6 million people worldwide with AD 
in 2010, and it is predicted that 1 in 85 people will be affected by 2050 (Brookmeyer et al. 
2007). So far, there is no treatment for the disease, which worsens as it progresses, and 
eventually leads to death. Thus, it is very important to accurately identify AD, especially for 
its early stage also known as mild cognitive impairment (MCI) which has a high risk of 
progressing to AD (Petersen et al. 1999).
Existing studies have shown that AD is related to the structural atrophy, pathological 
amyloid depositions, and metabolic alterations in the brain (Jr et al. 2010; Nestor et al. 
2004). So far, multiple biomarkers have been shown to be sensitive to the diagnosis of AD 
and MCI, i.e., structural MR imaging (MRI) for brain atrophy measurement (Leon et al. 
2007; Du et al. 2007; Fjell et al. 2010; Mcevoy et al. 2009), functional imaging (e.g., FDG-
PET) for hypometabolism quantification (De et al. 2001; Morris et al. 2001), and 
cerebrospinal fluid (CSF) for quantification of specific proteins (Bouwman et al. 2007; 
Mattsson et al. 2009; Shaw et al. 2009; Fjell et al. 2010).
In recent years, machine learning and pattern classification methods, which can learn a 
model from training subjects to predict class label (i.e., patient or normal control) on unseen 
subject, have been widely applied to studies of AD and MCI based on single modality of 
biomarkers. For example, researchers have extracted the features from the structural MRI, 
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such as voxel-wise tissue (Desikan et al. 2009; Fan et al. 2007; Magnin et al. 2009), cortical 
thickness (Desikan et al. 2009; Oliveira et al. 2010) and hippocampal volumes (Gerardin et 
al. 2009; MJ et al. 2004) for AD and MCI classification. Besides structural MRI, some 
researchers also used fluorodeoxyglucose positron emission tomography (FDG-PET) 
(Chételat et al. 2003; Foster et al. 2007; Higdon et al. 2004) for AD or MCI classification.
Different imaging modalities provide different views of brain structure or function. For 
example, structural MRI reveals patterns of gray matter atrophy, while FDG-PET measures 
the reduced glucose metabolism in the brain. It is reported that MRI and FDG-PET provide 
different sensitivity for memory prediction between disease and health (Walhovd et al. 
2010). Using multiple biomarkers may reveal hidden information that could be overlooked 
by using single modality. Researchers have begun to integrate multiple modalities to further 
improve the accuracy of disease classification (Leon et al. 2007; Fjell et al. 2010; Foster et 
al. 2007; Walhovd et al. 2010; Apostolova et al. 2010; Dai et al. 2012; Gray et al. 2012; 
Hinrichs et al. 2011; Huang et al. 2011; Landau et al. 2010; Westman et al. 2012; L. Yuan et 
al. 2012; D. Zhang et al. 2011). For instance, Hinrichs et al. (Hinrichs et al. 2011) used two 
modalities (including MRI and FDG-PET) for AD classification. Zhang et al. (D. Zhang et 
al. 2011) combined MRI, FDG-PET and cerebrospinal fluid (CSF) for classifying patients 
with AD/MCI from normal controls. Dai et al. (Dai et al. 2012) integrated structural MRI 
(sMRI) and functional MRI (fMRI) for AD classification. Gray et al. (Gray et al. 2012) used 
MRI, FDG-PET, CSF and categorical genetic information for AD/MCI classification.
Although promising results were achieved by existing multimodal classification methods, 
the problem of small number of subjects and large feature dimensions limits further 
performance improvement of the above methods. For neuroimaging data, even after feature 
extraction, the dimension of feature is still relatively high compared to the size of subject. 
Also, there may exist redundant or irrelevant features for subsequent classification task. 
Thus, those irrelevant and redundant features need to be removed for reducing feature 
dimension by feature selection. In the literature, most existing feature selection methods are 
often performed for each modality individually, which ignores the potential relationship 
among different modalities. To the best of our knowledge, only a few studies focus on 
jointly selecting features from multi-modality neuroimaging data for AD/MCI classification. 
For example, Huang et al. (Huang et al. 2011) proposed a sparse composite linear 
discriminant analysis model (SCLDA) for identification of disease-related brain regions of 
early AD from multi-modality data. Zhang and Shen (D. Zhang and Shen 2012) proposed a 
multi-modal multi-task learning for joint feature selection for AD classification and 
regression. Liu et al. (F. Liu et al. 2014) proposed inter-modality relationship constrained 
multi-task feature selection for AD/MCI classification. Jie et al. (Jie et al. 2015) presented a 
manifold regularized multi-task feature selection method for multimodal classification of 
AD/MCI. However, except for Jie et al.’s work, most of the existing multi-modality feature 
selection methods focus on using multi-modality information from the same subjects, while 
ignoring the intrinsic relationship across different subjects, which may also contain useful 
information for further improving the classification performance. Different from Jie et al.’s 
method, the proposed approach not only considers the information of each modality, but also 
regards the relationship across different modalities as extra information. Hence, Jie et al.’s 
method can be regarded as a special case of our proposed method.
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In this paper, we propose a novel learning method that can fully explore the relationships 
across both modalities and subjects through mining and fusing discriminative features from 
multi-modality data for AD/MCI classification. Specifically, our proposed learning method 
includes two major steps: 1) label-aligned multi-task feature selection, and 2) multimodal 
classification. First, we treat the feature selections from multi-modality data as different 
learning tasks and adopt a group sparsity regularizer to ensure a subset of relevant features to 
be jointly selected from multi-modality data. Moreover, to utilize the discriminative 
information among labeled subjects, we introduce a new label-aligned regularization term 
into the objective function of standard multi-task feature selection. Here, label-alignment 
means that all multi-modality subjects with the same class label should be closer in the new 
feature-reduced space. Then, we use a multi-kernel support vector machine (SVM) to fuse 
the selected features from multi-modality data for final classification. The proposed method 
has been evaluated on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, 
demonstrating better results compared to several state-of-the-art multi-modality-based 
methods.
II. Method
A. Neuroimaging Data
We use the data obtained from the Alzheimer’s disease Neuroimaging Initiative (ADNI) 
database (www.loni.usc.edu) in this paper. The ADNI was launched in 2003 by the National 
Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering 
(NIBIB), the Food and Drug Administration (FDA), private pharmaceutical companies and 
non-profit organizations, as a $60 million, 5-year public-private partnership. Determination 
of sensitive and specific markers of very early AD progression is intended to aid researchers 
and clinicians to develop new treatments and monitor their effectiveness, as well as lessen 
the time and cost of clinical trials. The initial goal of ADNI was to recruit approximately 
200 cognitively normal older individuals to be followed for three years, 400 MCI patients to 
be followed for three years, and 200 early AD patients to be followed for two years.
We use imaging data from 202 ADNI participants with corresponding baseline MRI and 
FDG-PET data. In particular, it includes 51 AD patients, 99 MCI patients and 52 normal 
controls (NC). The MCI patients were divided into 43 MCI converters (MCI-C) who have 
progressed to AD with 18 months and 56 MCI non-converters (MCI-NC) whose diagnoses 
have still remain stable within 18 months. Table I lists the clinical and demographic 
information for the study population. A detailed description on acquiring MRI and PET 
from ADNI as used in this paper can be found in (D. Zhang et al. 2011). All structural MR 
scans were acquired from 1.5 T scanners. Raw Digital Imaging and Communications in 
Medicine (DICOM) MRI scans were downloaded from the public ADNI site 
(adni.loni.usc.edu), reviewed for quality, and automatically corrected for spatial distortion 
caused by gradient nonlinearity and B1 field inhomogeneity. PET images were acquired 30–
60 minutes post-injection, averaged, spatially aligned, interpolated to a standard voxel size, 
intensity normalized, and smoothed to a common resolution of 8 mm full width at half 
maximum.
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Image pre-processing and feature extraction are performed for all MR and PET images by 
following the same procedures as in (D. Zhang et al. 2011). First, we do anterior 
commissure (AC)-posterior commissure (PC) correction on all images, and use the N3 
algorithm (Sled et al. 1997) to correct the intensity inhomogeneity. Next, we do skull-
stripping on structural MR images using both brain surface extractor (BSE) (Shattuck et al. 
2001) and brain extraction tool (BET) (Smith and Stephen 2002), followed by manual 
edition and intensity inhomogeneity correction. After removal of cerebellum, FAST in the 
FSL package (Y. Zhang et al. 2001) is used to segment structural MR images into three 
different tissues: gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). 
After registration using HAMMER (Shen and Davatzikos 2002), we obtain the subject-
labeled image based on a template with 93 manual labels. Then, we compute the GM tissue 
volume of each region as a feature. For PET image, we first align it to its respective MR 
image of the same subject using a rigid transformation, and then compute the average 
intensity of each ROI in the PET image as a feature. Therefore, for each subject, we totally 
obtain 93 features from MR image and another 93 features from PET image.
B. Label-aligned Multi-task Feature Learning
In this section, we will first briefly introduce the conventional multi-task feature selection 
(Evgeniou and Pontil 2004; Kumar and Daume Iii 2012; Obozinski et al. 2010; Obozinski et 
al. 2006; M. Yuan and Lin 2006), and then derive our proposed label-aligned multi-task 
feature selection model, as well as the corresponding optimization algorithm. Finally, we use 
the multi-kernel support vector machine for classification. Fig. 1 gives the overview of the 
proposed classification method.
1) Multi-task feature selection—Denote  as the 
training data matrix on the m-th modality, where  represents the corresponding (column) 
feature vector of the i-th subject, d is the dimension of features, and N is the number of 
subjects. Let Y = [y1, …, yi, …, yN]T ∈ ℝN be the label vector corresponding to N training 
samples, where the value of yi is +1 or −1 (i.e., patient or normal control). Then, the 
objective function of multi-task feature selection (MTFS) model is as follows (M. Yuan and 
Lin 2006):
(1)
where wm ∈ ℝd is the regression coefficient vector for the m-th modality and the coefficient 
vectors for all M modalities form a coefficient matrix, W = [w1, …, wm, …, wM] ∈ ℝd×M 
and M is the total number of modalities. In (1), ‖W‖2,1 is the ℓ2,1-norm of matrix W defined 
as , where wj is the j-th row of matrix W. Here, λ1 is a regularization 
parameter controlling the relative contributions of the two terms.
The ℓ2,1-norm ‖W‖2,1 can be seen as the sum of the ℓ2-norms of the rows of matrix W (M. 
Yuan and Lin 2006), which encourages the weights corresponding to the same feature across 
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different modalities to be grouped together and then a small number of common features 
will be jointly selected. So, the solution of MTFS results in a weight matrix W whose 
elements in many rows are all zeros for the characteristic of ‘group sparsity’. It is worth 
noting that when there is only one modality (i.e., M =1), the MTFS model will degenerate 
into the least absolute shrinkage and selection operator (LASSO) model (Tibshirani 1994).
2) Label-aligned multi-task feature selection—One limitation of the standard multi-
task feature selection model is that only the relationship between modalities of the same 
subjects is considered, while ignoring the important relationship among labeled subjects. To 
address this issue, we introduce a new term called label-aligned regularization term, which 
minimizes the distance between within-class subjects in the feature-reduced space as 
follows:
(2)
where, Sij is defined as:
(3)
The regularization term (2) can be explained as follows. 
measures the distance between  and  in the projected space. It implies that if  and 
are from the same class, the distance between them should be as small as possible in the 
projected space. It is worth noting that 1) when p = q the local geometric structure of the 
same modality data is preserved in the feature-reduced space; 2) when p < q the 
complementary information provided from different modalities are used to guide the 
estimation of the feature-reduced space. Therefore, the equation (2) preserves the intrinsic 
label relatedness among multi-modality data and also explores the complementary 
information conveyed by different modalities. Generally speaking, the goal of (2) is to 
preserve label relatedness by aligning paired within-class subjects from multiple modalities.
By incorporating the regularizer (2) into (1), we can obtain the objective function of our 
label-aligned multi-task feature selection model as below:
(4)
where λ1 and λ2 are the two positive constants that control the sparseness and the degree of 
preserving the distance between subjects, respectively. From (4), we can not only jointly 
select a subset of common features from multi-modality data, but also preserve label 
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relatedness by aligning paired within-class subjects. Fig. 2 illustrates the used relationships 
among modalities and subjects in our proposed model as compared with the traditional 
multi-modality methods. In Fig. 2(a), traditional multimodal methods only concern the 
relationships of different modalities (i.e., the single line connecting MRI and PET) from the 
same subject. As we can see from Fig. 2(b), our proposed method can preserve not only the 
multi-modality relationship from the same subject, but also the correlation across modalities 
between different subjects.
3) Optimization algorithm—At present, there are several algorithms developed to solve 
the optimization problem in (4). Here, we choose the widely applied Accelerated Proximal 
Gradient (APG) method (Nesterov 2003; Chen et al. 2009) to get the solution of our 
proposed method. Specifically, we separate the objective function in (4) to the smooth part: 
and non-smooth part:
(5)
and non-smooth part:
(6)
Then, the following function is constructed for approximating the composite function f(W) + 
g(W):
(7)
where ‖·‖F is the Frobenius norm, ∇f(Wk) is the gradient of f(W) at point Wk of the k-th 
iteration, and l is the step size. Finally, the update step of AGP algorithm is defined as:
(8)
where l can be determined by line search, and .
The key of AGP algorithm is how to solve the update step efficiently. The study in (J. Liu 
and Ye 2010) shows that this problem can be decomposed into d separate subproblems, and 
the analytical solutions of these sub-problems can be easily obtained.
In addition, according to the technique in (Chen et al. 2009), instead of computing (7) based 
on Wk, we use Qk to calculate Ωl(W, Qk) and the search point Qk is defined as:
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(9)
where  and . The algorithm for Eq. (4) can achieve a convergence 
rate of O(1 / K2), where K is the maximum iteration.
C. Multi-kernel Support Vector machine
Multi-kernel SVM can effectively integrate data from multiple modalities for classification 
of Alzheimer’s disease (D. Zhang et al. 2011). Given a set of training subjects, m = 1, … M, 
 is the kernel function for the subjects  and  of the m-
th modality. Linear combined kernel,  is adopted for fusing 
information from different modalities. Here βm is the combining weight of the m-th kernel 
and . In our experiments, the optimal βm is determined via a coarse-grid search 
through cross-validation on the training set.
III. Experiments and Results
We test the performance of the proposed method on 202 ADNI participants with 
corresponding baseline MRI and FDG-PET data. Classification performance is assessed 
between three clinically relevant pairs of diagnostic groups (AD vs. NC, MCI vs. NC, and 
MCI-C vs. MCI-NC). The proposed method is compared with three existing multi-kernel-
based multimodal classification methods, including multi-kernel method (D. Zhang et al. 
2011) without performing feature selection (denoted as Baseline), multi-kernel method with 
LASSO feature selection performed independently on single modalities (denoted as SMFS), 
and multi-kernel method using multi-modal feature selection method (denoted as MMFS) 
proposed in (D. Zhang and Shen 2012). We also directly concatenate 93 features from MRI 
and 93 features from FDG-PET into a 186 dimensional vector, and then perform t-test and 
LASSO as feature selection methods, followed by the standard SVM with linear kernel for 
classification (with the corresponding methods denoted as t-test and LASSO, respectively). 
It is worth noting that the same training and test subjects are used in all methods for fair 
comparison.
A. Validation
In our experiments, we use a 10-fold cross-validation strategy to evaluate the effectiveness 
of our proposed method. Specifically, the whole set of subject samples are equally 
partitioned into 10 subsets. For each cross-validation, the nine subsets are chosen for 
training and the remaining subjects are used for testing. The process is independently 
repeated 10 times to avoid any bias introduced by randomly partitioning the dataset in cross-
validation. We evaluate the performance of different methods by computing the 
classification accuracy (ACC), as well as the sensitivity (SEN), the specificity (SPE) and the 
area under receiver operating characteristic (ROC) curve (AUC). Here, the accuracy 
measures the proportion of subjects correctly classified among the whole population, the 
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sensitivity represents the proportion of AD or MCI patients correctly classified, and the 
specificity denotes the proportion of normal controls correctly classified. The SVM classifier 
is implemented using the LIBSVM toolbox (Chang and Lin 2007), with a linear kernel and a 
default value for the parameter C (i.e., C = 1). The optimal values of regularization 
parameters λ1, λ2 and the weights in the multi-kernel classification method are determined 
by another 10-fold cross-validation on the training subjects.
B. Results of AD/MCI vs. NC Classification
The classification results of AD vs. NC and MCI vs. NC produced by different methods are 
listed in Table II. As can be seen from Table II, our proposed method consistently achieves 
better performance than other methods for the classification between AD/MCI patients and 
normal controls. Specifically, for classifying AD from NC, our proposed method achieves a 
classification accuracy of 95.95%, while the best accuracy of other methods is only 92.25% 
(obtained by SMFS). In addition, for classifying MCI from NC, our proposed method 
achieves a classification accuracy of 80.26%, while the best accuracy of other methods is 
only 74.34% (obtained by Baseline). Furthermore, we perform the significance test using 
paired t-test on the classification accuracies between our proposed method and other 
compared methods, with the corresponding results given in Table II. From Table II, we can 
see that our proposed method is significantly better than the compared methods (i.e., the 
corresponding p values are very small).
For further validation, in Fig. 3 we plot the ROC curves of four multi-modality based 
classification methods for AD/MCI vs. NC classification. Fig. 3 shows that our proposed 
method consistently achieves better classification performances than other multi-modality 
based methods for both AD vs. NC and MCI vs. NC classifications. Specifically, as can be 
seen from Table II, our method achieves the area under the ROC curve (AUC) of 0.97 and 
0.81 for AD vs. NC and MCI vs. NC classifications, respectively, showing better 
classification ability compared with other methods.
C. Results of MCI Conversion Prediction
The classification results for MCI-C vs. MCI-NC are shown in Table III. As can be seen 
from Table III and Fig. 4, our proposed method consistently outperforms other methods in 
MCI-converter classification. Specifically, our proposed method achieves a classification 
accuracy of 69.78%, while the best one of other methods is only 61.67%, which is obtained 
by SMFS. The classification accuracy of our proposed method is significantly (p < 0.001) 
higher than any compared methods.
Fig. 4 plots the corresponding ROC curves of four multi-modality based methods for MCI-C 
vs. MCI-NC classification. We can see from Fig. 4 that the superior classification 
performance is obtained by our proposed method. Table III also lists the area under the ROC 
curve (AUC) of different classification methods. As can be seen from Table III, AUC 
achieved by our proposed method is 0.69 for MCI-C vs. MCI-NC classification, while the 
best one of other methods is only 0.64, obtained by t-test, indicating the outstanding 
classification performance of our proposed method.
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The most discriminative regions are defined as those that are most frequently selected in 
cross-validation. For each selected discriminative feature, the standard paired t-test is 
performed to evaluate its discriminative power between patients and normal control groups. 
Top 10 ROIs detected from both MRI and FDG-PET data for MCI classification are listed in 
Table IV. Fig. 5 plots these regions in the template space. As can be seen from Table IV and 
Fig. 5, the most important regions for MCI classification include hippocampal, amygdale, 
etc., which are in agreement with other recent AD/MCI studies (Sole et al. 2008; Derflinger 
et al. 2011; Al 2008; St et al. 2011; Wolf et al. 2003).
IV. Discussion
In this paper, we proposed a novel label-aligned multi-task feature learning method for 
multimodal classification of Alzheimer’s disease and mild cognitive impairment. The 
experimental results on the ADNI database show that our proposed method achieves high 
classification accuracies of 95.95%, 80.26%, and 69.78% for AD vs. NC, MCI vs. NC and 
MCI-C vs. MCI-NC classifications, in comparison with several state-of-the-art multimodal 
AD/MCI classification methods.
A. Multi-task Learning
Multi-task learning is a recently developed technique in machine learning field, which can 
jointly learn multiple tasks via a shared representation. Because the domain information or 
some commonality is contained in the learning tasks, multi-task learning can usually 
improve the performances by learning classifiers for multiple tasks together.
Recently, multi-task learning has been introduced into medical imaging field. For example, 
Zhang et al. (D. Zhang and Shen 2012) applied multi-task learning for joint prediction of 
both regression variables (i.e., clinical scores) and classification variable (i.e., class labels) in 
Alzheimer’s disease. In their method, multi-task feature selection was first used to select the 
common subset features corresponding to different tasks, and then multi-kernel SVM was 
performed for final regression and classification. It is worth noting that the feature selection 
step in (D. Zhang and Shen 2012) was performed separately for each modality, while 
ignoring the potential relationship among different modalities. Afterwards, Liu et al. (F. Liu 
et al. 2014) considered the inter-modality relationship within each subject to preserve the 
complementary information among modalities. However, in their method only information 
corresponding to individual subject is concerned. Suk et al. (Suk et al. 2014) first assumed 
the data classes were multipeak distribution, and then formulated a multi-task learning 
problem in a R-2,1 framework with new label encodings obtained by clustering. However, 
the method in (Suk et al. 2014) still did not consider the potential information across 
different modalities. More recently, Jie et al. (Jie et al. 2015) proposed a manifold 
regularized multi-task feature learning method, which only considered the manifold 
information in each modality separately and thus cannot reflect the information across 
different modalities. It is worth noting that our proposed method and Jie et al.’s method are 
developed based on different considerations. Jie et al.’s method only concerns preserving the 
manifolds existing in each modality of the data. Different from Jie et al.’s method, the 
proposed approach not only takes the structure information of each modality into account, 
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but also regards the relationship across different modalities as extra information. Hence, Jie 
et al.’s method can be regarded as a special case of our proposed method. Although our 
proposed method has a more general feature selection framework compared with Jie et al.’s 
approach, the objective function of our method is still convex. Thus, the optimal solution can 
still be obtained, i.e., by using Accelerated Proximal Gradient (APG) method.
In contrast, our proposed label-aligned multi-task feature learning method can preserve the 
relationships not only across different modalities in the same subjects but also among 
different modalities in different subjects. Our proposed method is evaluated on the ADNI 
database using baseline MRI and FDG-PET data for three clinical groups classifications 
including AD vs. NC, MCI vs. NC and MCI-C vs. MCI-NC, and the experimental results 
demonstrate the effectiveness of our proposed method.
B. Comparison with Existing Methods
To compare our proposed method with existing methods, in this section we perform the 
comparisons between the results of our proposed method and those of existing state-of-the-
art multi-modality methods, as shown in Table V. As can be seen from Table V, Hinrichs et 
al. (Hinrichs et al. 2011) used 48 AD subjects and 66 NC subjects, and obtained an accuracy 
of 87.6% by using two modalities (MRI + PET). Huang et al. (Huang et al. 2011) used 49 
AD patients and 67 NC with MRI and PET modalities for AD classification, achieving an 
accuracy of 94.3%. In (Gray et al. 2012), authors used 37 AD patients, 75 MCI patients and 
35 NC and reported classification accuracies of 89.0%, 74.6% and 58.0% for AD, MCI and 
MCI-converter classification, respectively, using four different modalities (MRI+PET+CSF
+genetic). Jie et al. (Jie et al. 2015) achieved the accuracies of 95.03%, 79.27% and 68.94% 
for classification of AD/NC, MCI/NC and MCI-C/MCI-NC, respectively. Liu et al. (F. Liu et 
al. 2014) obtained the accuracies of 94.37%, 78.80% and 67.83% for AD, MCI and MCI-
converter classifications, respectively. It is worth noting that the dataset used in (Jie et al. 
2015) and (F. Liu et al. 2014) are the same as that in the current study. Table V indicates that 
our proposed method consistently outperform other methods, which further validate the 
efficacy of our proposed method for AD diagnosis.
C. The Effect of Regularization Parameters
In our method, there are two regularization items, i.e., the sparsity regularizer λ1 and label-
aligned regularization term λ2. The two parameters control the relative contribution of those 
regularization terms. Here, the values of λ1 and λ2 are set from 0 to 50 at a step size of 10, 
respectively, to observe the effect of the regularization parameters on the classification 
performance of our proposed method. Fig. 6 shows the classification results with respect to 
different values of λ1 and λ2. When λ1 = 0, all features extracted from MRI and FDG-PET 
data are used for classification, and thus our method will degenerate to multi-kernel method 
proposed in (D. Zhang et al. 2011). Also, when λ2 = 0, no label-aligned regularization item 
is introduced, and thus our method will degenerate to the MMFS method proposed in (D. 
Zhang and Shen 2012).
As we can observe from Fig. 6, under all values of λ1 and λ2, our proposed method 
consistently outperforms the MMFS methods on three classification tasks (i.e., AD vs. NC, 
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MCI vs. NC, and MCI-C vs. MCI-NC), which further indicates the advantage of using label-
aligned regularization term. Also, Fig. 6 shows that when fixing the value of λ1, the curves 
corresponding to different values of λ2 are very smooth on three classification tasks, which 
shows our method is relatively robust to the regularization parameter λ2. Finally, as can be 
seen from Fig. 6, when fixing the value of λ2, the results on three classification tasks are 
largely affected with different values of λ1, which implies that the selection of λ1 is very 
important for final classification results. This is reasonable since λ1 controls the sparsity of 
model and thus determines the size of the optimal feature subset.
D. The Effect of Weights for Multimodal Classification
We investigate how the two combining kernel weights βMRI and βPET affect the 
classification performance of our proposed method. The combining kernel weights are set 
from 0 to 1 at a step size of 0.1, with the constraint of βMRI + βPET = 1. Fig. 7 shows the 
classification accuracy and AUC value under different combination of kernel weights of 
MRI and PET. As we can observe from Fig. 7, the relative high classification performance is 
obtained in the middle part, which demonstrates the effectiveness of combining two 
modalities for classification. Moreover, the intervals with higher performance mainly lie in a 
larger interval of [0.2, 0.8], implying that each modality is indispensable for achieving good 
classification performances.
E. Limitations
There are several limitations that should be further considered in the future study. First, in 
the current study, we only investigated binary classification problem (i.e., AD vs. NC, MCI 
vs. NC, and MCI-C vs. MCI-NC), and did not test the ability of the classifier for the multi-
class classification of AD, MCI and normal controls. Although multi-class classification is 
more challenging than binary-class classification, it is very important to diagnose different 
stage of dementia. Second, the proposed method requires the same number of features from 
different modalities. Other modalities in ADNI database, such as CSF and genetic data, 
which have different feature numbers, may also carry important pathological information 
that can help further improve the classification performance. Finally, longitudinal data may 
contain very important information for classification, while our proposed method can only 
deal with the baseline data.
V. Conclusion
This paper proposed a novel multi-task feature learning method for jointly selecting features 
from multi-modality neuroimaging data for AD/MCI classification. By introducing the 
label-aligned regularization term into the multi-task learning framework, the proposed 
method can utilize the relationships across both modalities and subjects to seek out the most 
discriminative features subset. Experimental results on the ADNI database demonstrate that 
our proposed method outperforms the state-of-the-art methods for multimodal classification 
of AD/MCI.
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Fig. 1. 
Schematic illustration of the proposed classification pipeline.
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Fig. 2. 
Illustrations on the relationship among modalities and subjects in (a) traditional multi-
modality methods and (b) proposed method in identifying subjects in class 1 and class 2. 
Circles and rectangles represent MRI and PET data, respectively. Red and blue denote 
different classes.
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Fig. 3. 
ROC curves of four multi-modality based methods. (a) Classification of AD vs. NC, (b) 
Classification of MCI vs. NC.
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Fig. 4. 
ROC curves of four multi-modality based methods for classification of MCI converters.
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Fig. 5. 
Top 10 ROIs selected by the proposed method for MCI.
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Fig. 6. 
The classification accuracy with regularization parameters λ1 and λ2. (a) AD classification, 
(b) MCI classification, and (c) MCI conversion classification. Each curve denotes the 
performance for different selected value for λ1. X-axis represents diverse values for λ2.
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Fig. 7. 
The classification results on three classification tasks with respect to different combining 
weights of MRI and PET (Top: classification accuracy; Bottom: AUC value).
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TABLE IV
Top 10 ROIs Selected by the Proposed Method for MCI classification
Selected ROIs MRI FDG-PET
Entorhinal cortex left p < 0.0001 p = 0.0286
Hippocampal formation left p < 0.0001 p = 0.0109
Angular gyrus left p = 0.0309 p < 0.0001
Amygdala right p < 0.0001 p = 0.0352
Precuneus left p = 0.0001 p = 0.0005
Hippocampal formation right p < 0.0001 p = 0.0309
Cuneus left p = 0.0741 p = 0.0626
Temporal pole left p = 0.0004 p = 0.0624
Middle temporal gyrus left p < 0.0001 p = 0.0816
Occipital pole left p = 0.1638 p = 0.0390
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